மொழிபெயர்ப்பு ஆராய்ச்சி ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மொழிபெயர்ப்பு ஆராய்ச்சி ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மொழிபெயர்ப்பு ஆராய்ச்சி ப்ரோக்ர்யாம் Today - Breaking & Trending Today

Dana-Farber announces expanded joint research agreement with Novartis


This 30-year collaboration is unique in its longevity and open scientific exchange.
Aiming to accelerate the translation of scientific discoveries into improved cancer therapies, Dana-Farber Cancer Institute and Novartis have renewed a longstanding research collaboration and – for the first time – are inviting grant applications from a broad range of Boston academic medical institutions. Under this renewal, more than $11 million will be available annually for research funding through the Dana-Farber/Novartis Drug Discovery and Translational Research Program (DDTRP).
The collaboration, which began in 1992, brings together scientists from Dana-Farber and Novartis to work on drug discovery and development efforts and has supported more than 700 research projects since inception. ....

United States , Harvard School Of Public Health , Dana Farber Cancer Institute , William Hahn , Jay Bradner , James Griffin , Piotr Sicinski , Anne Fassl , Kevin Haigis , Michael Eck , Broad Institute , Novartis Institutes For Biomedical Research , Translational Research Program , Beth Israel Deaconess Medical Center , Drug Administration , Harvard Medical School , Dana Farber Harvard Cancer Center , Novartis Drug Discovery , Chief Operating Officer , Novartis Institutes , Harvard Cancer Center , Boston Children , Massachusetts General Hospital , Harvard School , Public Health , Chief Scientific Officer ,

TS Alliance Advocates for Prioritization of Rare Disease Patients and Caregivers for COVID-19 Vaccines


Share this article
Share this article
SILVER SPRING, Md., March 3, 2021 /PRNewswire/  In partnership with more than 70 advocacy groups, healthcare providers, and biotech companies, the Tuberous Sclerosis Alliance (TS Alliance), an internationally recognized nonprofit that raises awareness and funds to fight the rare genetic disease tuberous sclerosis complex (TSC), recently issued a letter to the National Governors Association that calls on states to immediately prioritize Americans with life-threatening rare diseases in their COVID-19 vaccine rollouts.
In late January, President Biden announced a strategy committed to vaccine distribution for high-risk individuals, specifically those with underlying conditions, including rare diseases. However, the 25-30 million individuals in the United States with rare diseases and their caregivers have yet to be prioritized in many states. The letter has already been submitted to several states and will be presented to every s ....

University Of Cincinnati , United States , Neils Belloff , Patroski Lawson , Kari Rosbeck , Kyle Fink , Wendy Chung , Jill Silverman , Jeffreyr Buchhalter , Amit Rakhit , Jeremy Levin , Darcya Krueger , Peterb Crino , Jaye Isham , Mustafa Sahin , Ciliary Dyskinesia Foundation , Translational Neuroscience Center , National Alliance For Caregiving , Danny Did Foundation , Arts Alliance , University Of Cincinnati College Medicine , International Foundation , Angelman Syndrome Foundation , Therapeutics Inc , Childhood Epilepsy Surgery Foundation , University Of Maryland School Medicine ,